Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension

por Fleseriu, Maria, Newell-Price, John, Pivonello, Rosario, Shimatsu, Akira, Auchus, Richard J, Scaroni, Carla, Belaya, Zhanna, Feelders, Richard A, Vila, Greisa, Houde, Ghislaine, Walia, Rama, Izquierdo, Miguel, Roughton, Michael, Pedroncelli, Alberto M, Biller, Beverly M K
Publicado 2022